These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8237919)

  • 1. A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome.
    Hull C; Hagerman RJ
    Am J Dis Child; 1993 Nov; 147(11):1236-41. PubMed ID: 8237919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct DNA testing for fragile X syndrome.
    Ramos FJ; Eunpu DL; Finucane B; Pfendner EG
    Am J Dis Child; 1993 Nov; 147(11):1231-5. PubMed ID: 7901988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1.
    Franke P; Leboyer M; Gänsicke M; Weiffenbach O; Biancalana V; Cornillet-Lefebre P; Croquette MF; Froster U; Schwab SG; Poustka F; Hautzinger M; Maier W
    Psychiatry Res; 1998 Aug; 80(2):113-27. PubMed ID: 9754690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular-clinical correlations in children and adults with fragile X syndrome.
    Staley LW; Hull CE; Mazzocco MM; Thibodeau SN; Snow K; Wilson VL; Taylor A; McGavran L; Weiner D; Riddle J
    Am J Dis Child; 1993 Jul; 147(7):723-6. PubMed ID: 8322740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental status and fragile X expression in relation to FMR-1 gene mutation.
    de Vries BB; Wiegers AM; de Graaff E; Verkerk AJ; Van Hemel JO; Halley DJ; Fryns JP; Curfs LM; Niermeijer MF; Oostra BA
    Eur J Hum Genet; 1993; 1(1):72-9. PubMed ID: 8069653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular/clinical correlations in females with fragile X.
    Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome.
    Laxova R
    Adv Pediatr; 1994; 41():305-42. PubMed ID: 7992687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length.
    Smits A; Smeets D; Hamel B; Dreesen J; de Haan A; van Oost B
    Am J Med Genet; 1994 Jul; 51(4):497-500. PubMed ID: 7943027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobehavioral characteristics of CGG amplification status in fragile X females.
    Thompson NM; Gulley ML; Rogeness GA; Clayton RJ; Johnson C; Hazelton B; Cho CG; Zellmer VT
    Am J Med Genet; 1994 Dec; 54(4):378-83. PubMed ID: 7726212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic involvement in females with the FMR1 gene mutation.
    Riddle JE; Cheema A; Sobesky WE; Gardner SC; Taylor AK; Pennington BF; Hagerman RJ
    Am J Ment Retard; 1998 May; 102(6):590-601. PubMed ID: 9606468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging fragile X premutation phenotype: evidence from the domain of social cognition.
    Cornish K; Kogan C; Turk J; Manly T; James N; Mills A; Dalton A
    Brain Cogn; 2005 Feb; 57(1):53-60. PubMed ID: 15629215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fragile X family with high penetrance in females: risk heterogeneity?
    Martínez F; Badía L; Prieto F
    Clin Genet; 1992 Jul; 42(1):22-6. PubMed ID: 1355415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.
    McConkie-Rosell A; Lachiewicz AM; Spiridigliozzi GA; Tarleton J; Schoenwald S; Phelan MC; Goonewardena P; Ding X; Brown WT
    Am J Hum Genet; 1993 Oct; 53(4):800-9. PubMed ID: 8213810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of the fragile X mutation from a male with a full mutation: unusual somatic instability in the FMR-1 locus.
    Kambouris M; Snow K; Thibodeau S; Bluhm D; Green M; Feldman GL
    Am J Med Genet; 1996 Aug; 64(2):404-7. PubMed ID: 8844092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology of the fragile X syndrome.
    Tsongalis GJ; Silverman LM
    Arch Pathol Lab Med; 1993 Nov; 117(11):1121-5. PubMed ID: 8239933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
    Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
    Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.